Short-term progestin treatments prevent estrous induction by a GnRH agonist implant in anestrous bitches

Abstract

The objective of this study was to test the efficacy and safety of a short-term progestin treatment administered at two different times to prevent estrous induction in response to the administration of an implant releasing the GnRH agonist, deslorelin acetate (DA), in anestrous bitches. Interestrous intervals (IEI) observed prior to and post DA were compared. Forty-two anestrous bitches, with previous IEI history, were randomly allocated to one of the following treatments: PL: placebo sc ( n = 12); MA: megestrol acetate 2 mg/kg po for 8 days ( n = 4); DA: 10 mg sc ( n = 8); MA&DA-1: MA beginning the day before DA ( n = 8); and MA&DA-4: MA beginning 4 days before DA ( n = 10). The dose of MA was identical for each treatment. All bitches were examined daily for 1 month and then every 3 months until the next spontaneous post-treatment estrous cycle. Post-GnRH estrous response occurred in 0, 0, 100, 50, and 10% of the PL, MA, DA, MA&DA-1, MA&DA-4, groups, respectively (<0.01). There was an interaction between the treatment and period for the duration of the IEI (<0.01). Changes in IEI were different among treatments ( p < 0.01); the three DA-treated groups (147.5% ± 10.3, 161.3% ± 14.1, 148.6% ± 19.2) differed from both the MA (12.9% ± 17.6) and PL (8.1% ± 7.8), but not among themselves. It is concluded that an 8 days megestrol protocol and DA on Day 4 was better than DA on Day 1 to prevent estrous response in anestrous bitches and that both protocols significantly increased the IEI.